Full Description
Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.
Contents
Section I: Introduction
1. Introduction to antiviral therapy
Section II: Viral infections and transmission
2. Emerging viral diseases
3. Evolution and transmission of viruses
4. Mode of viral infections and transmissions
5. Transmission and Intervention Dynamics of SARS-CoV-2
6. Sexually transmitted viral infections
7. Testing of viral infections
8. Electron microscopic methods for virus diagnosis
Section III: Antiviral agents and therapeutics
9. Virotherapy
10. Challenges in designing antiviral agents
11. Anti-influenza agents
12. Anti-herpes virus agents
13. Antiretroviral Therapies
14. Rotavirus and anti-rotaviral agents: Trends and advances
15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses
16. Antiviral agents against flaviviruses
17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat
18. Herbal drugs to combat viruses
19. Strategies for delivery of antiviral agents
20. Nanovesicles for delivery of antiviral agents
21. Antiviral biomaterials
22. Antiviral biomolecules from marine inhabitantsBalasubramanian
23. Plant polysaccharides as antiviral agents
24. Antiviral peptides against dengue virus
25. mRNA vaccines for COVID-19
26. Immunotherapy as an emerging and promising tool against viral infections
27. Role of nutraceuticals as immunomodulators to combat viruses
Section IV: Others
28. In vitro and in vivo approaches for evaluating antiviral efficacy
29. Clinical trials and regulatory considerations of antiviral agents
30. Future perspectives of antiviral therapy
